Navigation Links
Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business

WAYNE, N.J., Jan. 6, 2012 /PRNewswire/ -- Cascade Medical Enterprises, LLC (CME), a leading company with proprietary platelet-rich plasma (PRP) and platelet-rich fibrin matrix (PRFM) technology for use in orthopedic therapeutic applications in soft tissue and bone repair, announced the sale of their technology to Musculoskeletal Transplant Foundation (MTF) and distribution by ConMed Linvatec for the worldwide orthopedic, dental, and wound care markets.

CME has had a long collaborative US distribution relationship with MTF for the sale of their products in the sports medicine market.  This collaboration has enabled the companies to achieve a formative market presence establishing CME as a science-based provider of a unique technology for the collection, preparation, and delivery of an autologous blood-derived platelet and fibrin biologic. The CME technology has been developed into procedure specific systems and kits, marketed as the CASCADE® System.  The key proprietary aspects of the CASCADE® technology are the ability to produce liquid, gel, and membrane formats for the PRP and PRFM to meet the needs of the specific procedure technique requirements.

The CASCADE® System is an FDA 510(k) cleared device that is designed to be used for the safe and rapid preparation of autologous PRP from a small sample of blood at the patient point of care.  The PRP can be mixed with autograft and allograft bone prior to the application to an orthopedic surgical site as deemed necessary by the clinical use requirements.

Autologous PRP and PRFM are biologic preparations that are derived from the patient's own blood.  Platelets are known to contain growth factors that stimulate the body's natural healing of soft tissue and bone.  The collection and concentration of these factors from a small sample of blood using systems that are safe, easy to use, and designed to maximize performance are unique to the CASCADE® technology.  In addition to the platelets, the CASCADE® System collects and prepares a fibrin matrix that acts as a scaffold to enable cell migration into the repair site.  Numerous scientific and clinical papers have been published.

See MTF's web site: for more information

Tony Dimun, Chairman of CME said "We are pleased that our collaboration with MTF has led to this exciting opportunity to expand the reach of our technology with the sale of our technology to MTF and distribution by ConMed Linvatec on a worldwide basis. We are proud of our accomplishments in partnership with MTF in bringing this exciting autologous technology to the worldwide market."

Nicholas Grippi, President and founder of CME, said "Our long relationship with MTF in building science-based support for our technology has established CME's recognition as the leading edge of autologous biologics therapy." 

Frank DeBernardis, CEO of CME, said "The MTF Sports Medicine Marketing and Sales organization did an excellent job of pioneering the markets for autologous biologics. We are pleased to continue our support for MTF and ConMed Linvatec in the ongoing product development of this exciting technology. Additionally, this relationship will enable CME to focus on our emerging Aesthetic Factors® and Vertical Spine™ business ventures." 

"MTF has been pleased to work with CME over the past several years promoting their unique PRP technology.  With this acquisition, we will now have the opportunity to greatly expand the promotion of CASCADE® PRP through our new partnership with ConMed Linvatec for the worldwide orthopedic, dental, and wound care markets," said Bruce Stroever, President and CEO of MTF.

SOURCE Cascade Medical Enterprises, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
2. PartsSource Wins Cascade Capital Award for Employee Growth
3. RT Oncology Services Signs Distribution Agreement with Metro Medical Supply, Inc.
4. Narang Medical Introduces NET Multifix Nails: Same Nail That Can be Used for Right and Left Legs
5. Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
6. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
7. Medical Marijuana Player, Cannabis Science Issues Earnings Guidance for 2012 Forecasted at $6,846,000 and Potential Increased to $65,740,000 in 2014 with $0.02 Per Share Positive Earnings
8. Cantel Medical Corp. to Present at the Needham & Company 14th Annual Growth Conference
9. Medical Korea Offers 2011 Awards to Top Medical Tourism Service Providers (Institutions)
10. Acid Attack Victim from Malaysia Restores Her Lost Face with Support of Medical Korea
11. Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
Post Your Comments:
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):